rxstat › Shortages › Latanoprost
Latanoprost shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Latanoprost products are in shortage in Canada (4 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 25, 2026.
In shortage since
May 8, 2024
Est. full return
Aug 25, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMYLAN-LATANOPROST
50MCG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02373041 · since Jun 25, 2026, est. end Aug 25, 2026 · Disruption of the manufacture of the drug.
Active shortageM-LATANOPROST
50MCG · SOLUTION · MANTRA PHARMA INC
DIN 02513285 · since ?, est. end Aug 15, 2026 · Delay in shipping of the drug.
Active shortageAPO-LATANOPROST
50MCG · SOLUTION · APOTEX INC
DIN 02296527 · since Feb 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageTEVA-LATANOPROST
50MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02254786 · since May 8, 2024, no end estimate · Disruption of the manufacture of the drug.
AnticipatedMONOPROST
50MCG · SOLUTION · LABORATOIRES THEA
DIN 02456230 · Delay in shipping of the drug.
ResolvedSANDOZ LATANOPROST
50MCG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02367335 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
ResolvedJAMP LATANOPROST
50MCG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02453355 · ended May 8, 2026 · Demand increase for the drug.
ResolvedJAMP LATANOPROST
50MCG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02453355 · ended Apr 15, 2026 · Demand increase for the drug.
ResolvedSANDOZ LATANOPROST
50MCG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02367335 · ended Feb 23, 2026 · Delay in shipping of the drug.
ResolvedSANDOZ LATANOPROST
50MCG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02367335 · ended Nov 14, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ LATANOPROST
50MCG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02367335 · ended Aug 11, 2025 · Demand increase for the drug.
ResolvedAPO-LATANOPROST
50MCG · SOLUTION · APOTEX INC
DIN 02296527 · ended Jun 26, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 34 reports. All reports are on file with Health Canada.
What's happening
Latanoprost is currently affected by 4 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, MANTRA PHARMA INC, APOTEX INC, TEVA CANADA LIMITED.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Latanoprost is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01EE).
Recent changes
Common questions
When will Latanoprost be back in stock in Canada?
The latest manufacturer estimate is Aug 25, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Latanoprost in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.